p.122 抽出テキスト

731. Gudbjartsson DF, Holm H, Sulem P, et al. A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation. Eur Heart J 2017; 38: 27-34. PMID: 27742809 732. Hodgson-Zingman DM, Karst ML, Zingman LV, et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 2008; 359: 158-165. PMID: 18614783 733. Thorolfsdottir RB, Sveinbjornsson G, Sulem P, et al. A Missense Variant in PLEC Increases Risk of Atrial Fibrillation. J Am Coll Cardiol 2017; 70: 2157-2168. PMID: 29050564 734. Chalazan B, Freeth E, Mohajeri A, et al. Genetic testing in monogenic early-onset atrial fibrillation. Eur J Hum Genet 2023; 31: 769-775. PMID: 37217627 735. Ellinor PT, Lunetta KL, Albert CM, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012; 44: 670-675. PMID: 22544366 736. Roselli C, Chaffin MD, Weng LC, et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet 2018; 50: 1225- 1233. PMID: 29892015 737. Nielsen JB, Thorolfsdottir RB, Fritsche LG, et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet 2018; 50: 1234-1239. PMID: 30061737 738. Miyazawa K, Ito K, Ito M, et al. BioBank Japan Project. Crossancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nat Genet 2023; 55: 187-197. PMID: 36653681 739. Sakai T, Furutani M, Nakashima M, et al. Genome-Wide Association Study of Atrial Fibrillation Recurrence After Radiofrequency Catheter Ablation in a Japanese Population. J Cardiovasc Electrophysiol 2025; 36: 1494-1503. PMID: 40296270 740. Goodyer WR, Dunn K, Caleshu C, et al. Broad Genetic Testing in a Clinical Setting Uncovers a High Prevalence of Titin Lossof-Function Variants in Very Early Onset Atrial Fibrillation. Circ Genom Precis Med 2019; 12: e002713. PMID: 31638414 741. Yoneda ZT, Anderson KC, Quintana JA, et al. Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes. JAMA Cardiol 2021; 6: 1371-1379. PMID: 34495297 742. Kany S, Jurgens SJ, Rämö JT, et al. Genetic testing in earlyonset atrial fibrillation. Eur Heart J 2024; 45: 3111-3123. PMID: 39028637 743. Vad OB, Monfort LM, Paludan-Müller C, et al. Geisinger MyCode Community Health Initiative and the Regeneron Genetics Center (RGC) Research Team. Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk. JAMA Cardiol 2024; 9: 732-740. PMID: 38922602 744. 日本循環器学会,日本不整脈心電学会.2020 年改訂版 不整脈薬物治療ガイドライン.https://www.j-circ.or.jp/cms/wp-content/ uploads/2020/01/JCS2020_Ono.pdf 745. Olivotto I, Cecchi F, Casey SA, et al. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001; 104: 2517-2524. PMID: 11714644 746. Guttmann OP, Rahman MS, O’Mahony C, et al. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart 2014; 100: 465-472. PMID: 24014282 747. Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58: e212-e260. PMID: 22075469 748. Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733-2779. PMID: 25173338 749. Zhao DS, Shen Y, Zhang Q, et al. Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis. Europace 2016; 18: 508-520. PMID: 26612881 750. Providencia R, Elliott P, Patel K, et al. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis. Heart 2016; 102: 1533-1543. PMID: 27234160 751. Pierri A, Albani S, Merlo M, et al. Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based Analysis. JACC Adv 2024; 3: 100899. PMID: 38939638 752. Mommersteeg MT, Hoogaars WM, Prall OW, et al. Molecular pathway for the localized formation of the sinoatrial node. Circ Res 2007; 100: 354-362. PMID: 17234970 753. Mommersteeg MT, Brown NA, Prall OW, et al. Pitx2c and Nkx2-5 are required for the formation and identity of the pulmonary myocardium. Circ Res 2007; 101: 902-909. PMID: 17823370 754. Hill MC, Kadow ZA, Li L, et al. A cellular atlas of Pitx2-dependent cardiac development. Development 2019; 146: dev180398. PMID: 31201182 755. Parvez B, Vaglio J, Rowan S, et al. Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation. J Am Coll Cardiol 2012; 60: 539-545. PMID: 22726630 756. Syeda F, Kirchhof P, Fabritz L. PITX2-dependent gene regulation in atrial fibrillation and rhythm control. J Physiol 2017; 595: 4019- 4026. PMID: 28217939 757. Syeda F, Holmes AP, Yu TY, et al. PITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers. J Am Coll Cardiol 2016; 68: 1881-1894. PMID: 27765191 758. Husser D, Adams V, Piorkowski C, et al. Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2010; 55: 747-753. PMID: 20170812 759. Benjamin Shoemaker M, Muhammad R, Parvez B, et al. Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablation. Heart Rhythm 2013; 10: 394-400. PMID: 23178686 760. Shoemaker MB, Bollmann A, Lubitz SA, et al. Common genetic variants and response to atrial fibrillation ablation. Circ Arrhythm Electrophysiol 2015; 8: 296-302. PMID: 25684755 761. Choi EK, Park JH, Lee JY, et al. Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success. J Am Heart Assoc 2015; 4: e002046. PMID: 26272656 762. Rattanawong P, Chenbhanich J, Vutthikraivit W, et al. A Chromosome 4q25 Variant is Associated with Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-Analysis. J Atr Fibrillation 2018; 10: 1666. PMID: 29988284 763. Reyat JS, Chua W, Cardoso VR, et al. Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation. JCI Insight 2020; 5: e139179. PMID: 32814717 764. Choe WS, Kang JH, Choi EK, et al. A Genetic Risk Score for Atrial Fibrillation Predicts the Response to Catheter Ablation. Korean Circ J 2019; 49: 338-349. PMID: 30808078 765. Ikenouchi T, Nitta J, Inaba O, et al. Embryological Classification of Arrhythmogenic Triggers Initiating Atrial Fibrillation. J Am Coll Cardiol 2024; 84: 2116-2128. PMID: 39453361 766. Morris GM, Kalman JM. Fibrosis, electrics and genetics. Perspectives in sinoatrial node disease. Circ J 2014; 78: 1272-1282. PMID: 24837708 767. Ishikawa T, Tsuji Y, Makita N. Inherited bradyarrhythmia: A diverse genetic background. J Arrhythm 2016; 32: 352-358. PMID: 27761158 768. 日本循環器学会.2023 年循環器疾患診療実態調査報告書.https:// www.j-circ.or.jp/jittai_chosa/media/jittai_chosa2022web_4revise20241021.pdf 769. Jensen PN, Gronroos NN, Chen LY, et al. Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol 2014; 64: 531-538. PMID: 25104519 770. Chiu SN, Lin LY, Wang JK, et al. Long-term outcomes of pediatric sinus bradycardia. J Pediatr 2013; 163: 885-889.e1. PMID: 23623512 771. 蒔田直昌,石川泰輔,住友直方,他.家族性洞不全症候群の遺伝的背景と臨床的特徴に関する研究.平成28 年度厚生労働科学研究費補助金(難治性疾患等政策研究事業(難治性疾患政策研究事業))『小児期心筋症の心電図学的抽出基準、心臓超音波学的診断基準の作成と遺伝学的検査を反映した診療ガイドラインの作成に関する研究』分担研究報告書.https://mhlw-grants.niph.go.jp/ system/files/2016/162051/201610062A_upload/201610062A0013. pdf 772. Ishikawa T, Ohno S, Murakami T, et al. Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction. Heart Rhythm 2017; 14: 717-724. PMID: 28104484 773. Benson DW, Wang DW, Dyment M, et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 2003; 112: 1019-1028. PMID: 14523039 774. Abe K, Machida T, Sumitomo N, et al. Sodium channelopathy